New York Times (blog)In Israel, a New Approach to Organ DonationNew York Times (blog)We hope that people will sign organ donor cards because they think it is the right thing to do, or that families will consent to donation after a loved one has had bra…
Celladon Gets $43M For Heart Failure Treatments – socalTech.com
Celladon Gets $43M For Heart Failure TreatmentssocalTech.comLa Jolla-based Celladon Corporation, a developer of biopharmaceuticals targeting cardiovascular disease, said Wednesday afternoon that it has raised $43M in a financing round. The round was le…
Research and Markets: Future US Molecular Diagnostics Market: Growth … – SunHerald.com
Research and Markets: Future US Molecular Diagnostics Market: Growth …SunHerald.com… trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the following categories: Infectious Diseases, Genetic…
Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified … – Virtual Press Office (press release)
Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified …Virtual Press Office (press release)ViroPharma Incorporated (NASDAQ: VPHM) today announced that data from the pivotal study for their orphan drug Plenadren® (hydrocortison…
Research and Markets: Future US Molecular Diagnostics Market: Growth … – Bradenton Herald
Research and Markets: Future US Molecular Diagnostics Market: Growth …Bradenton Herald… trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the following categories: Infectious Diseases, Gene…
Pivotal Data Demonstrating Efficacy Of Plenadren® (Hydrocortisone, Modified … – Daily Markets
Pivotal Data Demonstrating Efficacy Of Plenadren® (Hydrocortisone, Modified …Daily Markets16, 2012 /PRNewswire/ – ViroPharma Incorporated (NASDAQ:VPHM) today announced that data from the pivotal study for their orphan drug Plenadren® (hydrocortis…
Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified … – MarketWatch (press release)
Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified …MarketWatch (press release)16, 2012 /PRNewswire via COMTEX/ — ViroPharma Incorporated (NASDAQ:VPHM) today announced that data from the pivotal study for their orphan drug …
Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified … – PR Newswire (press release)
Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified …PR Newswire (press release)16, 2012 /PRNewswire/ — ViroPharma Incorporated (NASDAQ: VPHM) today announced that data from the pivotal study for their orphan drug Plenadren
Breakthrough in genetic causes for inherited heart failure – HealthCanal.com
Breakthrough in genetic causes for inherited heart failureHealthCanal.comNew research, part-funded by the British Heart Foundation, goes some way to unpicking the genetic causes of inherited heart failure. Dilated cardiomyopathy (DCM) is one of the lea…
SMC 'yes' for Roche's RoActemra, 'no' for Gilead's Cayston – Pharma Times
SMC 'yes' for Roche's RoActemra, 'no' for Gilead's CaystonPharma TimesThe group concluded that RoActemra was superior to placebo in reducing disease activity and fever in patients with persistent forms of the illness despite hav…